Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder

Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder

Abstract Introduction Anti-aquaporin-4 antibody-positive (AQP4-Ab+) neuromyelitis optica spectrum disorder (NMOSD) is a complement-mediated autoimmune disease in which unpredictable and relapsing attacks on the central nervous system cause irreversible and accumulating damage. Comparative efficacy o...

Full description

Bibliographic Details
Main Authors: Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, Jin Nakahara, Noriko Isobe, Diego Centonze, Sami Fam, Adrian Kielhorn, Jeffrey C. Yu, Jeroen Jansen, Ina Zhang
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-05-01
Series:Neurology and Therapy
Subjects:
Neuromyelitis optica
Aquaporin-4
Network meta-analysis
Ravulizumab
Eculizumab
Inebilizumab
Online Access:https://doi.org/10.1007/s40120-024-00597-7

Internet

https://doi.org/10.1007/s40120-024-00597-7

Similar Items